These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 16859738

  • 1. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
    Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Schwartz P, Yu H.
    Gynecol Oncol; 2006 Dec; 103(3):990-5. PubMed ID: 16859738
    [Abstract] [Full Text] [Related]

  • 2. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
    Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Risch HA, Puopolo M, Yu H.
    Clin Cancer Res; 2006 Feb 15; 12(4):1208-14. PubMed ID: 16489075
    [Abstract] [Full Text] [Related]

  • 3. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
    Lu L, Katsaros D, Wiley A, de la Longrais IA, Puopolo M, Yu H.
    Cancer Invest; 2008 Mar 15; 26(2):185-92. PubMed ID: 18259951
    [Abstract] [Full Text] [Related]

  • 4. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
    Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H.
    Cancer Res; 2007 Nov 01; 67(21):10117-22. PubMed ID: 17974952
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer.
    Sayer RA, Lancaster JM, Pittman J, Gray J, Whitaker R, Marks JR, Berchuck A.
    Gynecol Oncol; 2005 Feb 01; 96(2):355-61. PubMed ID: 15661221
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics.
    Qian B, Katsaros D, Lu L, Canuto EM, Benedetto C, Beeghly-Fadiel A, Yu H.
    Oncol Rep; 2011 Jan 01; 25(1):203-13. PubMed ID: 21109978
    [Abstract] [Full Text] [Related]

  • 9. [Insulin-like growth factor 2 imprinting status and promoter usage in the placenta of macrosomia].
    Yao JC, Hu YL, Wang ZQ, Dai YM, Ling JX, Ye XD.
    Zhonghua Fu Chan Ke Za Zhi; 2007 May 01; 42(5):309-14. PubMed ID: 17673042
    [Abstract] [Full Text] [Related]

  • 10. IGF-II promoter methylation and ovarian cancer prognosis.
    Beeghly AC, Katsaros D, Wiley AL, Rigault de la Longrais IA, Prescott AT, Chen H, Puopolo M, Rutherford TJ, Yu H.
    J Cancer Res Clin Oncol; 2007 Oct 01; 133(10):713-23. PubMed ID: 17569086
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Expression and prognostic significance in epithelial ovarian cancer].
    Katsaros D, Yu H, Piccinno R, Puopolo M, Rigault De La Longrais IA, Fracchioli S, Massobrio M.
    Minerva Ginecol; 2002 Feb 01; 54(1):15-24. PubMed ID: 11828267
    [Abstract] [Full Text] [Related]

  • 13. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K, Yamamoto H, Taniguchi H, Adachi Y, Yoshida Y, Arimura Y, Endo T, Hinoda Y, Imai K.
    Clin Cancer Res; 2004 Dec 01; 10(23):7950-7. PubMed ID: 15585629
    [Abstract] [Full Text] [Related]

  • 14. Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
    Mu L, Katsaros D, Wiley A, Lu L, de la Longrais IA, Smith S, Khubchandani S, Sochirca O, Arisio R, Yu H.
    Breast Cancer Res Treat; 2009 May 01; 115(1):151-62. PubMed ID: 18481170
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer.
    Chen CL, Ip SM, Cheng D, Wong LC, Ngan HY.
    Clin Cancer Res; 2000 Feb 01; 6(2):474-9. PubMed ID: 10690526
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Promoter usage for insulin-like growth factor-II in cancerous and benign human breast, prostate, and bladder tissues, and confirmation of a 10th exon.
    Mineo R, Fichera E, Liang SJ, Fujita-Yamaguchi Y.
    Biochem Biophys Res Commun; 2000 Feb 24; 268(3):886-92. PubMed ID: 10679300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.